CAS 104746-03-4
:R-10-MONOHYDROXY-DIHYDRO-CARBAMAZEPIN
Description:
R-10-Monohydroxy-Dihydro-Carbamazepin, identified by its CAS number 104746-03-4, is a chemical compound related to carbamazepine, a medication primarily used to treat epilepsy and bipolar disorder. This substance features a hydroxyl group, which contributes to its solubility and reactivity. The presence of the dihydro structure indicates that it has undergone partial hydrogenation, affecting its pharmacological properties. Typically, compounds like this may exhibit neuroprotective effects and can influence neurotransmitter activity in the central nervous system. The specific stereochemistry and functional groups present in R-10-Monohydroxy-Dihydro-Carbamazepin can significantly impact its biological activity, including its efficacy and side effect profile. As with many pharmaceutical compounds, understanding its characteristics, including solubility, stability, and interaction with biological targets, is crucial for its potential therapeutic applications. Further research is often necessary to fully elucidate its pharmacodynamics and pharmacokinetics.
Formula:C15H14N2O2
InChI:InChI=1/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m1/s1
SMILES:c1ccc2c(c1)C[C@H](c1ccccc1N2C(=N)O)O
Synonyms:- (10R)-10,11-Dihydro-10-Hydroxy Carbamazepine
- R-(-)-10,11-Dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide,R-MHD,CGP13698
- (10R)-10-hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
(R)-Licarbazepine
CAS:Formula:C15H14N2O2Color and Shape:White To Off-White SolidMolecular weight:254.29(R)-10-Monohydroxy-10,11-dihydro Carbamazepine
CAS:Controlled Product<p>Applications (R)-10-Monohydroxy-10,11-dihydro Carbamazepine is the metabolite of Oxcarbazepine (OXC) and Eslicarbazepine acetate, (BIA 2-093, ESL), novel central nervous system drugs. ee=98% [α]d=-193 (C=1, pyridine)<br>References Duncan, J., et al.: Br. J. Clin. Pharmacol., 53, 123 (2002), Almeida, L., et al.: J. Clin. Pharmacol., 45, 1062 (2005), Coppola, G., et al.: CNS Drugs, 18, 133 (2004),<br></p>Formula:C15H14N2O2Color and Shape:NeatMolecular weight:254.28(R)-10-Monohydroxy-10,11-dihydro Carbamazepine-d3
CAS:Controlled Product<p>Applications (R)-10-Monohydroxy-10,11-dihydro Carbamazepine-d3 is labelled (R)-10-Monohydroxy-10,11-dihydro Carbamazepine which is the metabolite of Oxcarbazepine (OXC) and Eslicarbazepine acetate, (BIA 2-093, ESL), novel central nervous system drugs.<br>References Duncan, J., et al.: Br. J. Clin. Pharmacol., 53, 123 (2002), Almeida, L., et al.: J. Clin. Pharmacol., 45, 1062 (2005), Coppola, G., et al.: CNS Drugs, 18, 133 (2004),<br></p>Formula:C15H11D3N2O2Color and Shape:White To Off-WhiteMolecular weight:257.3(R)-10-Monohydroxy-10,11-dihydro carbamazepine
CAS:<p>(R)-10-Monohydroxy-10,11-dihydro carbamazepine is a drug that has been shown to be active in vitro against human liver microsomes. It is a metabolite of carbamazepine, which is used for the treatment of neurologic disorders. (R)-10-Monohydroxy-10,11-dihydro carbamazepine has pharmacokinetic properties and plasma concentration–time curves similar to those of its parent compound. It also binds to hepatic CYP2C19 and CYP3A4 enzymes with high affinity, which leads to the inhibition of their activity. The drug has been shown to have a half life of 27 hours in CD1 mice, but it is not known how long it stays in humans.</p>Formula:C15H14N2O2Purity:Min. 95%Color and Shape:White To Off-White SolidMolecular weight:254.28 g/mol



